Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      The Galien Foundation Announces 2026 International Prix Galien Award Nominees

      International Prix Galien

      News provided by

      The Galien Foundation

      Aug 18, 2026, 09:00 ET

      Share this article

      Share this article


      Biennial Awards Ceremony to Honor "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product," "Best Product for Orphan/Rare Diseases," and "Best Startup"

      NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the 2026 International Prix Galien Awards. Presented every two years, eligible nominees have received a national Prix Galien award within the last two years in one of the following categories: "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product," "Best Product for Orphan/Rare Diseases," and "Best Startup."

      "This year's Prix Galien International Awards will be celebrated during a milestone chapter in the Foundation's history as we mark the 20th Anniversary of the Prix Galien USA edition," said Mr. Kenneth C. Frazier and Dr. Michael Rosenblatt, Co-Chairs of the Prix Galien USA Awards Committee. "The dedication, innovation, and collaboration of the teams behind this year's nominations are a testament to the bright future of the global life sciences industry."

      As stated in the International Prix Galien Regulations, the Chair of the host country's Prix Galien chapter serves as Chair of the International Prix Galien Committee. The International Judging Committee is composed of Chairs of the Prix Galien chapters worldwide.

      "Hosting the International Prix Galien Awards in the United States is both a great privilege and distinct opportunity to honor and showcase the latest generation of leaders across global health," said Frazier and Rosenblatt. "We extend our gratitude, on behalf of the International Awards Committee, toward this year's nominees for their relentless pursuit of improving health for people and the planet."

      "There is no greater setting to host both the International Prix Galien Awards and the 20th anniversary of the Prix Galien USA Awards than the 'city that never sleeps', which parallels the relentless efforts of innovators, researchers, and scientists from these global teams to pave the way for a healthier, stronger, and better future for people around the world," commented Bruno Cohen, Chairman of The Galien Foundation.

      The companies in the running for the 2026 International Prix Galien Awards include: 

      Best Biotechnology Product (Nominees)

      Bharat Serums and Vaccines Ltd.

      Trinbelimab (Anti D®)

      Biological E Ltd

      A Conjugate Vaccine to prevent Streptococcus pneumoniae infection in infants

      Daiichi Sankyo & AstraZeneca

      Enhertu®

      Regeneron and Sanofi

      Dupixent®

      Roche

      Glofitamab

      Takeda UK Ltd.

      Qdenga

      Best Digital Health Solution (Nominees)

      Evaxion

      AI-Immunology™ platform

      Linde Homecare France

      AIRGENIOUS™

      Medable

      Medable Agentic Clinical Development Platform

      Viz.ai

      Viz HCM™

      Best Medical Technology (Nominees)

      Biocon Biologics Limited          

      Pichia Pastoris platform for the production of Recombinant Human Insulin/ Insulin Glargine

      Butterfly Network, Inc.

      Butterfly iQ3

      Edwards Lifesciences

      Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System

      Insulet Corporation

      Omnipod® 5 Automated Insulin Delivery System

      Medtronic

      GI Genius™ Intelligent Endoscopy Module

      MiniMed

      MiniMed Flex™ system

      Novocure®

      Optune Gio®

      Best Pharmaceutical Product (Nominees)

      ARMATURA

      VIUSID

      AstraZeneca

      Tagrisso

      AstraZeneca and Merck & Co., Inc. (known as MSD outside the US and Canada)

      LYNPARZA

      BioMarin Pharmaceutical Inc.

      Pombiliti® with Opfolda®

      Gilead Sciences

      Yeztugo®

      Johnson & Johnson

      TECVAYLI® (teclistamab-cqyv)

      MSD

      KEYTRUDA

      MSD Italia

      Gardasil 9 - Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

      MSD Italia

      Vaxneuvance 15-valent conjugate vaccine suspension for injection

      Pfizer Inc.

      PAXLOVID™

      Sanofi and AstraZeneca

      Beyfortus®

      Servier

      TIBSOVO®

      Vertex Pharmaceuticals

      CASGEVY® (exagamglogene autotemcel)

      Best Product for Orphan/Rare Diseases (Nominees)

      Immunocore

      KIMMTRAK® (tebentafusp-tebn)

      MSD Sharp & Dohme GmbH

      Winrevair

      Novo Nordisk A/S

      Alhemo®

      Pierre Fabre Laboratories

      EBVALLO® (tabelecleucel)

      Servier

      VORANIGO®

      Best Startup (Nominees)

      Dren Bio


      InnAccel Technologies Private Limited

      Saans, VAPCare and Fetal Lite

      Parisodhana Technologies Pvt. Ltd.

      NeoWarm® - Neonatal Hypothermia Prevention Warm Blanket

      PENTAVERE

      (HEALWELL AI)

      Resuscitec GmbH


      International Prix Galien Awards Committee

      Pr. Awa Marie COLL SECK
      Minister of State to the President of the Republic of Senegal, President of the Scientific Committee of the Galien Forum Africa
      Africa

      Pr. Koen AUGUSTYNS
      Full Professor of Medicinal Chemistry at the University of Antwerp.
      Belgium/ Luxembourg

      Dr. Mikael DOSTEN
      Former Chief Scientific Officer & President, Worldwide Research, Pfizer. Board Member, Agilent Technologies, Rocket Pharmaceuticals, Chai Discovery, BenchSci, and Enveda Biosciences
      Bridges (Nordic+/Austria/Israel/Portugal/Spain)

      Pr. Ernesto L. SCHIFFRIN
      Physician-in-Chief, Dept. of Medicine, Jewish General Hospital; Director, Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research; Dist. James McGill Prof. and Assoc. Chair, Dept. of Medicine, McGill University
      Canada

      Dr. Annick TIBI
      Head of Clinical Trials Department, AGEPS, AP-HP, Associate Professor, Head of UP "Pharmaceutical Development and Innovation", Faculty of Pharmacy, University of Paris
      France

      Pr. Marianne DIETERICH, Director of the neurology clinic and outpatient department at the University Hospital of Ludwig Maximilian University of Munich (LMU).
      Germany

      Pr. George P. CHROUSOS
      Professor, School of Medicine, National and Kapodistrian School of Athens
      Greece

      Pr. Ashutosh SHARMA
      President, Indian National Science Academy
      India

      Pr. Pier Luigi CANONICO
      Professor Emeritus of Pharmacology, Università del Piemonte Orientale Amedeo Avogadro
      Italy

      Pr. Takashi KADOWAKI
      President of the Japanese Association of Medical Sciences
      Japan

      Pr. Yeong Min PARK
      CEO, Korea Drug Development Fund
      Korea

      Pr. Cezary SZCZYLIK
      Polish Professor of Medical Science Specializing in Oncology, Hematology and Internal Diseases
      Poland

      Pr. Christoph RENNER
      Professor of Hematology and Medical Oncology; Director, Medical Program for Cell Therapy, Klinik Hirslanden, Zurich
      Switzerland

      Pr. Dr. Lisette van GERMERT-PIJNEN
      Full Professor Persuasive Health Technology, University of Twente, and Visiting Professor, University of Waterloo
      The Netherlands

      Pr. Sir Munir PIRMOHAMED
      David Weatherall Chair of Medicine, University of Liverpool, UK
      United Kingdom

      Mr. Kenneth C. FRAZIER
      Retired Chairman and CEO, Merck & Co; Chairman, Health Assurance Initiatives, General Catalyst
      United States of America

      Dr. Michael ROSENBLATT
      Member, Harvard Board of Overseers Advisory Partner, Ascenta Capital; Senior Advisor, Bain Capital Life Sciences & Flagship Pioneering; Member, Harvard Board of Overseers
      United States of America

      About The Galien Foundation
      The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives. Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

      Today, the Prix Galien operates through 16 chapters spanning more than 75 countries across Africa, the Americas, Asia, and Europe. Expansion is currently underway in China, Singapore, and Australia.

      In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.

      The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognizes up to three individuals for specific discoveries, the Prix Galien honors the collaborative spirit and multidisciplinary progress that defines modern biopharmaceutical innovation.

      For more information, visit https://www.galienfoundation.org/

      Follow the Foundation on social media:
      https://www.facebook.com/GalienFoundation/ 
      https://twitter.com/GalienFdn
      https://www.linkedin.com/company/the-galien-foundation/

      Media Contact:
      Kara Bradley
      Finn Partners
      [email protected]
      +1 646-213-7243

      SOURCE The Galien Foundation

      Modal title

      Also from this source

      The Galien Foundation Announces 2026 Prix Galien Bridges Awards Nominees and Recipient of the Bengt I. Samuelsson "True North" Award

      The Galien Foundation Announces 2026 Prix Galien Bridges Awards Nominees and Recipient of the Bengt I. Samuelsson "True North" Award

      The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the annual...

      The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients

      The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients

      The Galien Foundation, the premier global institution dedicated to honoring innovation in the life sciences, celebrated the 20th anniversary of the...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Pharmaceuticals

      Pharmaceuticals

      Biotechnology

      Biotechnology

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.